project id: TCGA-OV; case submitter id: TCGA-13-2059; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.3; rna integrity number: 5.8; spectrophotometer method: UV Spec; age at index: 50; days to birth: -18449; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1959; age at diagnosis: 18449; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2387.0; figo stage: Stage IIIC; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 1.0; longest dimension: 2.0; preservation method: Unknown; shortest dimension: 0.4; sample id: 55a04faa-6302-4078-84d3-875fa4a9b56e; sample submitter id: TCGA-13-2059-01A; portion id: bdf8c53d-3282-494d-b76f-c05c3feb8b3f; portion submitter id: TCGA-13-2059-01A-01; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0;